Contract Manufacturing

Kimia Farma’s contract manufacturing service aims to make it easier for SMEs to capture market share in the pharmaceutical manufacturing industry by leveraging the competitive advantages of multiple companies and integrating them for unified growth. Our close ties to businesses involved in every step of the pharmaceutical manufacturing process have allowed us to develop a viable business model. We continue to seek new products and new companies that we can collaborate with to disrupt the status quo manufacturing landscape. The major benefits of using our contract manufacturing services are:

• Cost-efficiency by lowering operating costs by up to 40%
• Global approach, allowing companies to focus on their competitive advantages
• Manpower, technical knowhow, pre-approved manufacturing facilities and a vast sourcing and distribution network that would otherwise be unattainable or very expensive
• Tax benefits realized due to local manufacturing
• Immediate production capabilities without the need for setup and pre-approval
• Ability to expand product line without the need to add capacity

Kimia Farma is currently engaged in contract manufacturing operations with a publicly listed local manufacturer that has the following approvals in place:

• European (EU) GMP accredited by the German Ministry of Health (MOH)
• World Health Organization (WHO) GMP
• Accredited with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)
• Accredited with the Korean Food and Drug Administration (KFDA)
• Cofepris (Mexican accreditation) Certified (2014)
• OHSAS 18001: 2007
• ISO 14001: 2004